Keyphrases
Acitretin
8%
Adalimumab
8%
Biological Agents
8%
Body Area
16%
Calcipotriol
8%
Chronic Inflammatory Skin Disease
8%
Clinical Management
8%
Clinical Scenarios
8%
Clinical Signs
16%
Common Disease
8%
Corticosteroids
8%
Crohn's Disease
8%
Current Treatment
8%
Cyclosporine
8%
Dithranol
8%
Eczematous Lesions
8%
Efalizumab
8%
Elbow
16%
Epidemiology
8%
Erythematous Plaque
8%
Etanercept
8%
Extensor
8%
Histologic
8%
Infliximab
8%
Intergluteal Cleft
8%
Keratolytic
8%
Knee
8%
Knee Region
8%
Lymphoma
8%
Medical Conditions
100%
Methotrexate
8%
Mild Forms
8%
Moderate-to-severe Psoriasis
8%
Non-infectious
8%
Phototherapy
8%
Plaque
8%
Psoralen Plus Ultraviolet A
8%
Psoriasis
100%
Psoriasis Disease
8%
Psoriatic Arthritis
8%
Psoriatic Plaque
8%
Racial Groups
8%
Sacral Region
8%
Scalp
16%
Scenario Assessment
8%
Skin Biopsy
8%
Skin Lesions
8%
Skin Surface
8%
Systemic Conditions
8%
Systemic Disease
8%
Systemic Therapy
8%
Tazarotene
8%
Topical Preparation
8%
Topical Therapy
8%
Treatment Options
8%
Ultraviolet-B (UV-B)
8%
Western Countries
8%
Medicine and Dentistry
Adalimumab
7%
Biological Product
7%
Calcipotriol
7%
Clinical Management
7%
Cohort Effect
7%
Crohn's Disease
7%
Cyclosporine
7%
Dermatitis
7%
Dermatology
7%
Disease
7%
Dithranol
7%
Efalizumab
7%
Elbow
14%
Emollient Agent
7%
Etanercept
7%
Etretin
7%
Infliximab
7%
Intergluteal Cleft
7%
Keratolytic Agent
7%
Knee
14%
Methotrexate
7%
Psoralen
7%
Psoriasis
100%
Psoriatic Arthritis
7%
Racial Group
7%
Scalp
14%
Skin Biopsy
7%
Skin Defect
7%
Skin Surface
7%
Systemic Disease
7%
Systemic Therapy
7%
Tazarotene
7%
Topical Treatment
7%
Ultraviolet Phototherapy
7%